Fate Therapeutics Balance Sheet (2012-2026) | FATE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)			16.95M				30.38M				47.63M				35.14M				36.22M
Receivables - Accured (Quarter)	2.10M	1.70M	1.10M	1.40M	0.00M	1.00M	0.80M	0.90M	0.00M	1.00M	0.90M	0.90M	1.70M	1.90M	2.10M	2.00M	2.00M	1.40M	0.70M	0.80M
Assets
Current Assets
Cash & Equivalents (Quarter)	76.65M	129.18M	133.58M	64.74M	55.27M	82.09M	61.33M	42.02M	46.80M	33.33M	41.87M	121.32M	36.92M	37.91M	36.06M	44.92M	41.25M	40.62M	46.63M	174.80M
Receivables - Net (Quarter)	10.30M	7.31M	8.68M	13.85M	13.13M	10.22M	38.48M	13.50M	2.83M	1.54M	1.83M	0.86M	1.05M	4.13M	3.54M	2.41M	1.40M	0.68M	0.92M	0.70M
Receivables (Quarter)	10.30M	7.31M	8.68M	13.85M	13.13M	10.22M	38.48M	13.50M	2.83M	1.54M	1.83M	0.86M	1.05M	4.13M	3.54M	2.41M	1.40M	0.68M	0.92M	0.70M
Prepaid Assets (Quarter)	7.37M	7.70M	8.83M	11.45M	17.18M	19.97M	27.37M	15.49M	11.41M	12.90M	14.54M	9.97M	13.46M	9.24M	9.30M	5.39M	6.17M	5.15M	4.13M	4.00M
Current Assets (Quarter)	713.27M	693.71M	633.41M	599.08M	599.16M	535.33M	502.07M	437.89M	392.18M	364.17M	331.54M	394.38M	319.39M	310.29M	291.91M	248.22M	230.40M	221.25M	208.70M	179.53M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	59.21M	74.62M	91.53M	97.86M	103.12M	109.12M	110.02M	108.59M	106.33M	101.71M	96.84M	92.12M	87.53M	82.39M	64.38M	62.76M	61.10M	59.48M	56.92M	54.26M
Long-Term Investments (Quarter)	149.50M	124.88M	100.66M	67.94M	11.93M	13.94M	4.94M	3.91M	7.29M		0.98M	7.59M	47.16M	33.61M	27.66M	32.29M	26.10M	10.30M	1.47M
Long-Term Deferred Tax (Quarter)															1.15M				2.30M
Other Non-Current Assets (Quarter)	0.01M	15.23M	0.03M	15.23M	15.23M	15.23M	15.23M	0.03M	15.18M	0.01M	15.18M	0.01M	0.01M	0.01M	0.01M				10.23M	10.05M
Non-Current Assets (Quarter)	302.40M	290.86M	288.04M	259.31M	207.90M	214.02M	203.49M	192.45M	192.57M	179.61M	174.68M	175.52M	209.43M	184.68M	148.78M	150.45M	141.24M	122.42M	110.23M	105.39M
Assets (Quarter)	1,015.67M	984.57M	921.46M	858.39M	807.06M	749.35M	705.56M	630.34M	584.76M	543.79M	506.22M	569.89M	528.82M	494.97M	440.69M	398.67M	371.63M	343.67M	318.94M	284.92M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	5.77M	6.44M	8.61M	11.44M	8.42M	9.59M	8.27M	9.86M	7.51M	5.71M	4.72M	6.76M	5.50M	6.35M	9.37M	4.19M	4.04M	3.50M	2.66M	3.28M
Notes Payables (Quarter)
Payables (Quarter)	5.77M	6.44M	8.61M	11.44M	8.42M	9.59M	8.27M	9.86M	7.51M	5.71M	4.72M	6.76M	5.50M	6.35M	9.37M	4.19M	4.04M	3.50M	2.66M	3.28M
Accumulated Expenses (Quarter)	25.74M	12.20M	18.36M	35.11M	16.55M	17.40M	53.93M	6.03M	29.47M	28.54M	10.56M	5.41M	7.26M	23.58M	21.35M	5.19M	18.18M	7.39M	9.08M	13.64M
Other Accumulated Expenses (Quarter)	7.34M	10.80M	11.71M	13.03M	12.29M	18.90M	19.18M	10.23M	8.11M	8.63M	8.12M	18.65M	8.01M	10.50M	6.36M	6.77M	4.87M	3.86M	4.41M	3.96M
Short term Debt (Quarter)
Current Leases (Quarter)	5.07M	4.70M	5.58M	5.58M	5.72M	5.75M	5.63M	5.54M	5.79M	5.98M	6.18M	6.40M	6.64M	6.89M	7.42M	6.54M	5.66M	4.75M	4.56M	4.74M
Current Deferred Revenue (Quarter)	23.03M	23.55M	21.48M	22.57M	33.66M	35.24M	42.23M	1.74M	1.93M	1.11M	0.69M	0.16M		0.60M	0.39M	0.21M		0.01M	0.38M	0.58M
Total Current Liabilities (Quarter)	105.60M	91.88M	81.28M	77.91M	91.52M	103.94M	114.05M	48.65M	44.69M	41.33M	39.09M	45.37M	34.79M	37.42M	38.52M	28.16M	28.67M	28.11M	36.07M	30.69M
Non-Current Liabilities
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)	38.92M	32.56M	27.12M	22.53M	17.74M	12.41M
Pension (Quarter)								12.90M	12.90M	12.90M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	105.41M	104.36M	109.24M	107.94M	106.59M	105.16M	103.71M	102.07M	100.56M	98.98M	97.36M	95.67M	93.92M	92.08M	77.85M	76.78M	75.67M	74.49M	73.29M	72.05M
Other Non-Current Liabilities (Quarter)	12.87M	0.80M	24.17M	0.80M	9.93M	0.80M	3.86M	2.14M	1.75M	0.70M		2.74M	1.18M	1.94M	0.53M	0.25M	0.32M	6.59M	2.11M	2.11M
Total Non-Current Liabilities (Quarter)	250.73M	253.44M	218.45M	224.19M	216.65M	230.55M	217.76M	150.72M	145.25M	140.31M	137.80M	141.04M	130.65M	130.70M	121.44M	110.01M	109.95M	103.02M	109.64M	103.10M
Total Liabilities (Quarter)	263.60M	254.24M	242.62M	224.99M	226.58M	231.35M	221.62M	152.86M	147.00M	141.01M	137.80M	143.78M	131.84M	132.64M	121.97M	110.26M	110.27M	109.61M	111.75M	105.21M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	752.07M	730.33M	678.84M	633.39M	580.48M	518.00M	483.94M	477.47M	437.75M	402.78M	368.42M	426.12M	396.98M	362.33M	318.73M	288.41M	261.36M	234.07M	207.18M	179.71M
Shareholder's Equity (Quarter)	752.07M	730.33M	678.84M	633.39M	580.48M	518.00M	483.94M	477.47M	437.75M	402.78M	368.42M	426.12M	396.98M	362.33M	318.73M	288.41M	261.36M	234.07M	207.18M	179.71M
Liabilities and Shareholders Equity (Quarter)	1,015.67M	984.57M	921.46M	858.39M	807.06M	749.35M	705.56M	630.34M	584.76M	543.79M	506.22M	569.89M	528.82M	494.97M	440.69M	398.67M	371.63M	343.67M	318.94M	284.92M
Retained Earnings (Quarter)	-0.09M	-700.46M	-769.08M	-2.85M	-3.38M	-3.25M	-1.85M	-1069.68M	-1122.44M	-0.50M	0.01M	-0.19M	-1298.16M	-1345.84M	0.27M	0.19M	-1469.68M	-1501.93M	0.12M	-0.08M
Preferred Shares (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Treasury Shares (Quarter)	1.63M	1.76M	4.01M	5.79M	6.01M	5.84M	5.86M	3.97M	3.78M	3.37M	3.07M	3.47M	3.26M	6.21M	6.21M	7.24M	7.05M	6.65M	6.64M	9.29M
Shares Outstanding (Quarter)	94.27M	95.36M	2.79M	96.54M	96.86M	2.79M	97.29M	98.19M	98.52M	98.59M	98.63M	113.80M	113.85M	113.88M	113.93M	114.60M	114.66M	115.34M	115.36M	116.27M

Research Tools

Developers

Fate Therapeutics Balance Sheet (2012-2026) | FATE

Research Tools

Developers

Fate Therapeutics Balance Sheet (2012-2026) | FATE

Create an account

Sign In

Reset Password